The aryl hydrocarbon receptor (AhR) pathway as a regulatory pathway for cell adhesion and matrix metabolism

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 536-546

  Kung, Tiffany ^a   Murphy, K A ^a   White, L A ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

2,3,7,8 tetrachlorodibenzo p dioxin (TCDD); AhR; Development; Extracellular matrix (ECM); Matrix metalloproteinase (MMP)

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CADHERIN; ENVIRONMENTAL CHEMICAL; ESTROGEN RECEPTOR; FLAVONOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; RETINOIC ACID; TRANSFORMING GROWTH FACTOR BETA;

CELL ADHESION; CELL CYCLE REGULATION; CELL INTERACTION; CELL STRESS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR;

ANIMALS; CELL ADHESION; EMBRYONIC DEVELOPMENT; ENVIRONMENTAL POLLUTANTS; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN BINDING; RECEPTOR CROSS-TALK; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 59349094114     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.09.031     Document Type: Review

References (100)

1. Barouki R., Coumoul X., and Fernandez-Salguero P.M. FEBS Lett 581 (2007) 3608-3615
2. Nguyen L.P., and Bradfield C.A. Chem Res Toxicol 21 (2008) 102-116
3. Beischlag T.V., Luis Morales J., Hollingshead B.D., and Perdew G.H. Crit Rev Eukaryot Gene Expr 18 (2008) 207-250
4. Hankinson O. Annu Rev Pharmacol Toxicol 35 (1995) 307-340
5. Matikainen T., Perez G.I., Jurisicova A., Pru J.K., Schlezinger J.J., Ryu H.Y., et al. Nat Genet 28 (2001) 355-360
6. Kolluri S.K., Weiss C., Koff A., and Gottlicher M. Genes Dev 13 (1999) 1742-1753
7. Yin H., Li Y., and Sutter T.R. Exp Clin Immunogenet 11 (1994) 128-135
8. Jeon M.S., and Esser C. J Immunol 165 (2000) 6975-6983
9. Hoffer A., Chang C.Y., and Puga A. Toxicol Appl Pharmacol 141 (1996) 238-247
10. Cho Y.C., Zheng W., and Jefcoate C.R. Toxicol Appl Pharmacol 199 (2004) 220-238
11. Sadek C.M., Weitzel M.A., and Allen-Hoffmann B.L. Radiat Oncol Investig (1996)
12. Larsen M.C., Brake P.B., Pollenz R.S., and Jefcoate C.R. Toxicol Sci 82 (2004) 46-61
13. Weiss C., Faust D., Schreck I., Ruff A., Farwerck T., Melenberg A., et al. Oncogene 27 (2008) 2198-2207
14. Andrysik Z., Vondracek J., Machala M., Krcmar P., Svihalkova-Sindlerova L., Kranz A., et al. Mutat Res 615 (2007) 87-97
15. Hoelper P., Faust D., Oesch F., and Dietrich C. Arch Toxicol 79 (2005) 201-207
16. Daley W.P., Peters S.B., and Larsen M. J Cell Sci 121 (2008) 255-264
17. Riecke K., Grimm D., Shakibaei M., Kossmehl P., Schulze-Tanzil G., Paul M., et al. Arch Toxicol 76 (2002) 360-366
18. Nottebrock C., Riecke K., Kruse M., Shakibaei M., and Stahlmann R. Toxicology 226 (2006) 197-207
19. Thackaberry E.A., Jiang Z., Johnson C.D., Ramos K.S., and Walker M.K. Toxicol Sci 88 (2005) 231-241
20. Aragon A.C., Kopf P.G., Campen M.J., Huwe J.K., and Walker M.K. Toxicol Sci 101 (2008) 321-330
21. Morgan M.R., Humphries M.J., and Bass M.D. Nat Rev Mol Cell Biol 8 (2007) 957-969
22. Prell R.A., and Kerkvliet N.I. J Immunol 158 (1997) 2695-2703
23. Riecke K., Schmidt A., and Stahlmann R. Arch Toxicol 77 (2003) 358-364
24. McMillan B.J., McMillan S.N., Glover E., and Bradfield C.A. J Biol Chem 282 (2007) 12590-12597
25. Monteiro P., Gilot D., Le Ferrec E., Lecureur V., N'Diaye M., Le Vee M., et al. Biochem Biophys Res Commun 358 (2007) 442-448
26. Abe Y., Sinozaki H., Takagi T., Minegishi T., Kokame K., Kangawa K., et al. Reprod Biol Endocrinol 4 (2006) 27
27. Morito N., Yoh K., Fujioka Y., Nakano T., Shimohata H., Hashimoto Y., et al. Cancer Res 66 (2006) 812-819
28. Backlund M., and Ingelman-Sundberg M. Cell Signal 17 (2005) 39-48
29. Juan S.H., Lee J.L., Ho P.Y., Lee Y.H., and Lee W.S. Eur J Pharmacol 530 (2006) 1-8
30. Halbleib J.M., and Nelson W.J. Genes Dev 20 (2006) 3199-3214
31. Yan Q., Zhang Z.F., Chen X.P., Gutmann D.H., Xiong M., Xiao Z.Y., et al. Int J Oncol 32 (2008) 1057-1063
32. Niermann T., Schmutz S., Erne P., and Resink T. Biochem Biophys Res Commun 300 (2003) 943-949
33. Dietrich C., Faust D., Moskwa M., Kunz A., Bock K.W., and Oesch F. Int J Cancer 103 (2003) 435-439
34. Yin T., and Green K.J. Semin Cell Dev Biol 15 (2004) 665-677
35. Kanazawa Y., Ueda Y., Shimasaki M., Katsuda S., Yamamoto N., Tomita K., et al. Anticancer Res 28 (2008) 655-664
36. Chesire D.R., Dunn T.A., Ewing C.M., Luo J., and Isaacs W.B. Cancer Res 64 (2004) 2523-2533
37. Huang H., and He X. Curr Opin Cell Biol 20 (2008) 119-125
38. Palermo C., and Joyce J.A. Trends Pharmacol Sci 29 (2008) 22-28
39. Pocar P., Klonisch T., Brandsch C., Eder K., Frohlich C., Hoang-Vu C., et al. Toxicol Sci 89 (2006) 408-414
40. Wang F., Samudio I., and Safe S. Mol Cell Endocrinol 172 (2001) 91-103
41. Kohle C., Hassepass I., Bock-Hennig B.S., Walter Bock K., Poellinger L., and McGuire J. Arch Biochem Biophys 402 (2002) 172-179
42. Qiu D., Owen K., Gray K., Bass R., and Ellis V. Biochem Soc Trans 35 (2007) 583-587
43. Son D.S., and Rozman K.K. Arch Toxicol 76 (2002) 404-413
44. Mizuyachi K., Son D.S., Rozman K.K., and Terranova P.F. Reprod Toxicol 16 (2002) 299-307
45. Gohl G., Lehmkoster T., Munzel P.A., Schrenk D., Viebahn R., and Bock K.W. Carcinogenesis 17 (1996) 443-449
46. Yang J.H. Biochem Biophys Res Commun 257 (1999) 259-263
47. Ahn N.S., Hu H., Park J.S., Kim J.S., An S., Kong G., et al. Mutat Res 579 (2005) 189-199
48. Gaido K.W., and Maness S.C. Toxicol Appl Pharmacol 133 (1995) 34-42
49. Shimba S., Hayashi M., Sone H., Yonemoto J., and Tezuka M. Biochem Biophys Res Commun 272 (2000) 441-448
50. Visse R., and Nagase H. Circ Res 92 (2003) 827-839
51. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Mol Cell Biochem 253 (2003) 269-285
52. Murphy K.A., Villano C.M., Dorn R., and White L.A. J Biol Chem 279 (2004) 25284-25293
53. Villano C.M., Murphy K.A., Akintobi A., and White L.A. Toxicol Appl Pharmacol 210 (2006) 212-224
54. Andreasen E.A., Mathew L.K., and Tanguay R.L. Toxicol Sci 92 (2006) 254-269
55. Vogel C.F., Sciullo E., and Matsumura F. Cardiovasc Toxicol 4 (2004) 363-373
56. Igarashi T.M., Bruner-Tran K.L., Yeaman G.R., Lessey B.A., Edwards D.P., Eisenberg E., et al. Fertil Steril 84 (2005) 67-74
57. Haque M., Francis J., and Sehgal I. Cancer Lett 225 (2005) 159-166
58. Santiago-Josefat B., Mulero-Navarro S., Dallas S.L., and Fernandez-Salguero P.M. J Cell Sci 117 (2004) 849-859
59. Schmidt J.V., Su G.H., Reddy J.K., Simon M.C., and Bradfield C.A. Proc Natl Acad Sci USA 93 (1996) 6731-6736
60. Gonzalez F.J., Fernandez-Salguero P., Lee S.S., Pineau T., and Ward J.M. Toxicol Lett 82-83 (1995) 117-121
61. Lahvis G.P., Lindell S.L., Thomas R.S., McCuskey R.S., Murphy C., Glover E., et al. Proc Natl Acad Sci USA 97 (2000) 10442-10447
62. Hushka L.J., Williams J.S., and Greenlee W.F. Toxicol Appl Pharmacol 152 (1998) 200-210
63. Lee P.P., Hwang J.J., Mead L., and Ip M.M. J Cell Physiol 188 (2001) 75-88
64. Fata J.E., Leco K.J., Moorehead R.A., Martin D.C., and Khokha R. Dev Biol 211 (1999) 238-254
65. Hamm J.T., Sparrow B.R., Wolf D., and Birnbaum L.S. Toxicol Sci 54 (2000) 424-430
66. Lin T.M., Ko K., Moore R.W., Simanainen U., Oberley T.D., and Peterson R.E. Toxicol Sci 68 (2002) 479-487
67. Brown N.M., and Lamartiniere C.A. Environ Health Perspect 103 (1995) 708-713
68. Vorderstrasse B.A., Fenton S.E., Bohn A.A., Cundiff J.A., and Lawrence B.P. Toxicol Sci 78 (2004) 248-257
69. Takagi T.N., Matsui K.A., Yamashita K., Ohmori H., and Yasuda M. Teratog Carcinog Mutagen 20 (2000) 73-86
70. Flaws J.A., Sommer R.J., Silbergeld E.K., Peterson R.E., and Hirshfield A.N. Toxicol Appl Pharmacol 147 (1997) 351-362
71. Gray Jr. L.E., and Ostby J.S. Toxicol Appl Pharmacol 133 (1995) 285-294
72. Andreasen E.A., Spitsbergen J.M., Tanguay R.L., Stegeman J.J., Heideman W., and Peterson R.E. Toxicol Sci 68 (2002) 403-419
73. Antkiewicz D.S., Burns C.G., Carney S.A., Peterson R.E., and Heideman W. Toxicol Sci 84 (2005) 368-377
74. Bello S.M., Heideman W., and Peterson R.E. Toxicol Sci 78 (2004) 258-266
75. Lahvis G.P., Pyzalski R.W., Glover E., Pitot H.C., McElwee M.K., and Bradfield C.A. Mol Pharmacol 67 (2005) 714-720
76. Gill S.E., and Parks W.C. Int J Biochem Cell Biol 40 (2008) 1334-1347
77. Bai S., Thummel R., Godwin A.R., Nagase H., Itoh Y., Li L., et al. Matrix Biol 24 (2005) 247-260
78. Mathew L.K., Andreasen E.A., and Tanguay R.L. Mol Pharmacol 69 (2006) 257-265
79. Andreasen E.A., Mathew L.K., Lohr C.V., Hasson R., and Tanguay R.L. Toxicol Sci 95 (2007) 215-226
80. Mathew L.K., Sengupta S.S., Ladu J., Andreasen E.A., and Tanguay R.L. FASEB J (2008)
81. Stoick-Cooper C.L., Weidinger G., Riehle K.J., Hubbert C., Major M.B., Fausto N., et al. Development 134 (2007) 479-489
82. Rundhaug J.E. J Cell Mol Med 9 (2005) 267-285
83. Ivnitski I., Elmaoued R., and Walker M.K. Teratology 64 (2001) 201-212
84. Safe S., Wormke M., and Samudio I. J Mammary Gland Biol Neoplasia 5 (2000) 295-306
85. Bocchinfuso W.P., and Korach K.S. J Mammary Gland Biol Neoplasia 2 (1997) 323-334
86. Wiseman B.S., Sternlicht M.D., Lund L.R., Alexander C.M., Mott J., Bissell M.J., et al. J Cell Biol 162 (2003) 1123-1133
87. Potier M., Elliot S.J., Tack I., Lenz O., Striker G.E., Striker L.J., et al. J Am Soc Nephrol 12 (2001) 241-251
88. Marin-Castano M.E., Elliot S.J., Potier M., Karl M., Striker L.J., Striker G.E., et al. Invest Ophthalmol Vis Sci 44 (2003) 50-59
89. Mizumoto H., Saito T., Ashihara K., Nishimura M., Tanaka R., and Kudo R. Int J Cancer 100 (2002) 401-406
90. Tian Y. Biochem Pharmacol 77 (2009) 670-680
91. Ghosh S., May M.J., and Kopp E.B. Annu Rev Immunol 16 (1998) 225-260
92. Fan Z., Yang H., Bau B., Soder S., and Aigner T. Rheumatol Int 26 (2006) 900-903
93. Tan Z., Chang X., Puga A., and Xia Y. Biochem Pharmacol 64 (2002) 771-780
94. Murphy K.A., Quadro L., and White L.A. Vitam Horm 75 (2007) 33-67
95. Wang Y.A., Shen K., Wang Y., and Brooks S.C. Dev Dyn 234 (2005) 892-899
96. Koli K., Saharinen J., Hyytiainen M., Penttinen C., and Keski-Oja J. Microsc Res Tech 52 (2001) 354-362
97. Fernandez-Salguero P. Biochem Pharmacol 77 (2009) 700-712
98. Safe S. Toxicol Lett 120 (2001) 1-7
99. Yang X., Liu D., Murray T.J., Mitchell G.C., Hesterman E.V., Karchner S.I., et al. Oncogene 24 (2005) 7869-7881
100. Zudaire E., Cuesta N., Murty V., Woodson K., Adams L., Gonzalez N., et al. J Clin Invest 118 (2008) 640-650